The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review
Author:
Publisher
BMJ
Subject
General Medicine
Reference100 articles.
1. Leading causes of certification for blindness and partial sight in England and Wales;Bunce;BMC Public Health,2006
2. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema;Soheilian;Retina,2012
3. Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness;Raftery;Br J Opthalmol,2007
4. Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review;Schmucker;Br J Opthalmol,2011
5. A systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injections;van der Reis;Retina,2011
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Surgical and Nonsurgical Trauma;Ocular Pathology;2025
2. Intravitreal OZURDEX vs. Intravitreal Bevacizumab for Diabetic Macular Edema: A Comprehensive Review;Cureus;2024-03-23
3. Off-Label Uses of Ranibizumab and Aflibercept for Age-Related Macular Degeneration in Turkey;Journal of Current Ophthalmology;2023-01
4. Role of Anti-VEGF (Bevacizumab) in Management of Neovascular Glaucoma: A Review;Journal of Pharmaceutical Research International;2021-08-06
5. Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT;Health Technology Assessment;2021-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3